2025-12-23 - Analysis Report
Okay, let's break down this Lam Research Corp (LRCX) analysis.

**0. Overview:**

We are analyzing Lam Research Corp (LRCX) to determine its investment potential. We'll look at its historical performance compared to the S&P 500, recent stock indicators, news, analyst opinions, earnings, and financial health.

**1. Return Rate Comparison:**

*   **LRCX:** Lam Research Corp is a global supplier of wafer fabrication equipment and services to the semiconductor industry.
*   **LRCX Cumulative Return:** 258.61%
*   **VOO (S&P 500) Cumulative Return:** 100.88%
*   **Divergence:** LRCX has significantly outperformed the S&P 500, with a current divergence of 157.7%.  This divergence has fluctuated from -15.5 to 157.7, and the current divergence is at the maximum of that range (relative divergence: 100.0), suggesting the outperformance is at its peak within the examined timeframe.

**Alpha, Beta Analysis:**

*   **Alpha:** Consistently positive Alpha values indicate that LRCX has generally outperformed the market on a risk-adjusted basis *except* for recent years (2020-2025).  The large negative Alpha in 2022-2024 is concerning. The recent large positive Alpha for 2023-2025 is notable, but consider this value with other data points for confirmation.
*   **Beta:** The Beta values are around 1, indicating that LRCX's price tends to move in the same direction and magnitude as the market.  The 1.2 beta for 2017-2019 suggests slightly more volatility than the market during that period.
*   **CAGR:**  High CAGR values in some periods show strong growth. The recent negative CAGR values need further investigation. The 2023-2025 CAGR of 170% is a significant rebound.
*   **MDD:** High Maximum Drawdown (MDD) values indicate significant potential for losses.  Consistently high MDD across all periods is a risk factor.
*   **Cap(B):** The market capitalization has generally increased over time, reflecting the company's growth. The values range from 17.5B to 221B
*   **Summary:** Lam Research has shown a strong outperformance historically, indicated by the Alpha and Beta analysis, with some recent turbulence.

**2. Recent Stock Price Fluctuations:**

*   **Current Price:** 175.26
*   **Previous Close:** 172.27
*   **Change:** 1.74 (Indicates slight upward price movement today. The change, relative to the previous close, is small.)
*   **5-day SMA:** 163.90
*   **20-day SMA:** 159.63
*   **60-day SMA:** 152.1395

*   **Analysis:** The stock price is above all three moving averages, which is generally considered a bullish signal.  The 5-day SMA is above the 20-day SMA, which is above the 60-day SMA, further confirming the uptrend.

**3. RSI, PPO, and Expected Return:**

*   **MRI:** 0.8 (Medium Investment Recommended)
*   **RSI:** 62.30 (Slightly above neutral, suggesting some upward momentum, but not yet overbought.)
*   **PPO:** 0.2008 (Positive, indicating the short-term moving average is above the long-term moving average, supporting the bullish trend)
*   **Hybrid Signal:** "cash_0%_Buy 90% of cash" suggests a strong buy signal from the model.
*   **Recent Divergence Change:** 9.1 (+): 단기상승 (Short-term increase). This indicates a recent improvement in relative performance compared to the S&P 500.
*   **Expected Return:** 14.2% (Projected long-term outperformance over the S&P 500.)
*   **Analysis:** The indicators are generally positive, supporting a bullish outlook for LRCX.  The MRI indicates medium risk.

**4. Recent News & Significant Events:**

The news headlines are overwhelmingly positive:

*   Multiple reports of LRCX surging.
*   Analyst upgrades and bullish sentiment.
*   Hitting all-time highs based on 2026 prospects.
*   Brokers suggesting investment.

**4-2. Analyst Opinions:**

*   **Consensus:** "Buy"
*   **Mean Rating:** 1.79 (leaning towards "Buy")
*   **Number of Opinions:** 30 (reasonable coverage)
*   **Target Price:** Average target price of $166.13 is *below* the current price of $175.26, suggesting analysts, *on average*, believe the stock is currently overvalued.  However, the high target price of $210.00 indicates some analysts are very bullish.
*   **Recent Rating Changes:** Lack of details on recent rating changes makes it hard to say if momentum is in favor or not.

**5. Recent Earnings Analysis:**

| 날짜       | EPS  | 매출       |
|------------|------|------------|
| 2025-10-24 | 1.24 | 5.32 B$    |
| 2025-04-25 | 1.04 | 4.72 B$    |
| 2025-01-31 | 0.93 | 4.38 B$    |
| 2024-10-28 | 0.86 | 4.17 B$    |
| 2025-10-24 | 0.86 | 4.17 B$    |

**Analysis:**

*   Both EPS and revenue show a generally upward trend over the past few quarters.
*   The most recent quarter (2025-10-24) shows a strong performance in both EPS and revenue.
*   The EPS for the 2025-10-24 data points are duplicated, so needs more clarity about what is real data.

**6. Financial Information:**

**Revenue and Profitability:**

| Quarter      | Revenue    | Profit Margin |
|--------------|------------|---------------|
| 2025-09-30   | $5.32B     | 50.43%        |
| 2025-06-30   | $5.17B     | 50.08%        |
| 2025-03-31   | $4.72B     | 49.02%        |
| 2024-12-31   | $4.38B     | 47.37%        |
| 2024-09-30   | $4.17B     | 48.05%        |

**Analysis:**

*   Revenue is steadily increasing, indicating strong demand for Lam Research's products.
*   Profit margins are also consistently high and trending upwards, suggesting efficient operations.

**Capital and Profitability:**

| Quarter      | Equity     | ROE      |
|--------------|------------|----------|
| 2025-09-30   | $10.19B    | 15.39%   |
| 2025-06-30   | $9.86B     | 17.44%   |
| 2025-03-31   | $9.51B     | 13.99%   |
| 2024-12-31   | $8.81B     | 13.52%   |
| 2024-09-30   | $8.47B     | 13.18%   |

**Analysis:**

*   Equity is growing, suggesting the company is retaining earnings and/or raising capital effectively.
*   Return on Equity (ROE) is healthy and generally increasing, indicating that the company is effectively using shareholder equity to generate profits.

**7. Comprehensive Analysis (Summary):**

*   **Positive Factors:**
    *   Strong historical outperformance versus the S&P 500.
    *   Bullish technical indicators (SMA alignment, RSI, PPO).
    *   Overwhelmingly positive news sentiment.
    *   "Buy" analyst consensus, though target prices are mixed.
    *   Rising revenue, profit margins, equity, and ROE.
    *   "Hybrid Signal" suggests a buy position.
*   **Negative/Cautionary Factors:**
    *   High Maximum Drawdown (MDD) indicating risk.
    *   Recent negative Alpha values raise concerns about recent performance. The most recent period showed high return and alpha values, so should be considered in context.
    *   Average analyst target price is *below* the current price, suggesting overvaluation.
    *   Beta is around 1, indicating the stock has the same volatility as the market.
    *   Earnings data points are duplicated. Needs correction.
*   **Overall Recommendation:**

Based on the analysis, Lam Research appears to be a fundamentally strong company with significant growth potential. The technical indicators and recent news support a bullish outlook. *However*, the high MDD and the fact that the average analyst target price is below the current price suggest some caution is warranted. Before investing, further investigate and verify the earnings data.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.